Non-discretionary demand
Goods that always move
Medicines are essential and consumed continuously — volumes hold through cycles. The underlying inventory is fast-moving, not speculative.
Working capital, against an essential book.
Pharma distribution moves on working capital. We fund inventory and receivables across a network of distributors we own and operate — and we run it on software that gives lenders visibility the trade has never had.
What Kyoora is, in one minute
Kyoora is consolidating India's fragmented pharma distribution. We acquire and operate regional distributors — the businesses that connect roughly 3,000 manufacturers to about 9 lakh retail pharmacies through some 80,000 distributors and stockists — and we run them on one software platform we build and own.
Distribution is a working-capital business. A distributor buys inventory from manufacturers, holds it briefly, and sells it on to pharmacies — often on short credit. The faster and larger that cycle turns, the more capital it needs. That capital need is structural, recurring, and secured against real goods that always sell.
Pharma demand is non-discretionary. People take their medicines in every economy.
Essential demand, short cycles, real collateral.
Short cash-conversion
Capital that turns quickly
Inventory is held briefly and converts to receivables on short terms — a self-liquidating cycle rather than long-dated risk.
Secured against assets
Inventory and receivables
Facilities are backed by identifiable, saleable stock and a diversified book of pharmacy receivables across many counters.
Operated, not aggregated
One counterparty, many nodes
You engage Kyoora — a single, governed operator — rather than thousands of small, opaque distributors.
Software-level visibility
Real-time, not quarterly
Because the network runs on Pharma OS, inventory, orders, and collections are visible at the line-item level — the transparency lenders rarely get in this trade.
Diversification
Spread across corridors
Exposure is distributed across regions, distributors, and a long tail of pharmacies — no single counterparty concentration.
Capital that scales with the network.
Use of funds
Working
capital
capital
Funding inventory and receivables as we onboard distributors and grow GMV across corridors.
Structures we welcome
Secured
facilities
facilities
Inventory and receivables financing, cash-credit lines, and structured working-capital facilities.
What you get
Full
visibility
visibility
Reporting drawn directly from the operating system — collateral and collections you can actually see.
Specific facility sizes, terms, and security structures are shared under NDA. Tell us a little about your mandate and we'll set up a conversation with our finance team.
Let's explore a facility.
If you finance supply chains, distribution, or working capital in essential-goods sectors, the Kyoora book is built for exactly this kind of lending — secured, short-cycle, and unusually transparent.
Share your mandate and constraints, and we'll come back with the detail your credit team needs.
Direct line: finance@kyoora.com